Company Contents
Quick Facts & Snapshot
Summary
The global Beta Glucan market is entering a solid expansion phase, driven by immune-health positioning, clean-label demand, and expanding applications in food, nutraceuticals, and pharmaceuticals. Leading Beta Glucan market companies consolidate share through technology, regulatory know-how, and integrated supply chains. From US$ 0.59 Billion in 2025, the market is projected to reach US$ 0.97 Billion by 2032, reflecting a 7.40% CAGR.
Source: Secondary Information and ReportMines Research Team - 2026
Ranking Methodology
The ranking of Beta Glucan market companies is based on a composite scoring model that balances scale, growth, and strategic depth. Core inputs include estimated 2025 Beta Glucan revenue, three-year growth trajectory, project wins with global ingredient brands, and installed production capacity across yeast-, cereal-, and microbe-derived Beta Glucan. Technology differentiation, IP strength, and portfolio breadth across purity levels, solubility profiles, and application formats are evaluated. Service coverage, including formulation support, clinical substantiation, and regulatory assistance in key markets, carries significant weight. We also assess long-term supply contracts, co-development agreements, and backward integration into fermentation or milling. Each company is scored on a 0–100 index, normalized across peers, then ranked to reflect overall competitive positioning rather than size alone, providing an objective, investment-grade view of the leading Beta Glucan market companies.
Top 10 Companies in Beta Glucan
Source: Secondary Information and ReportMines Research Team - 2026
Detailed Company Profiles
Kerry Group plc (Wellmune & Beta Glucan Portfolio)
Kerry Group is a global taste and nutrition leader, offering clinically supported yeast Beta Glucan for immune-health foods, beverages, and supplements.
Cargill Incorporated
Cargill is a diversified agribusiness and ingredient company supplying cereal-based Beta Glucan fibers to global food and beverage manufacturers.
DSM-Firmenich AG
DSM-Firmenich is a science-driven nutrition innovator with strong presence in yeast and microbial Beta Glucan for nutraceutical and pharma markets.
Lesaffre Group (including Biospringer)
Lesaffre is a global yeast and fermentation specialist offering Beta Glucan for human, animal, and pet nutrition applications.
Tate & Lyle PLC
Tate & Lyle supplies fiber and sweetener solutions, integrating oat Beta Glucan into health-focused food and beverage formulations.
Biothera Pharmaceuticals, Inc.
Biothera is a specialized biotech company focused on highly purified Beta Glucan for immune modulation and medical nutrition.
Garuda International Inc.
Garuda International produces specialty oat and barley Beta Glucan ingredients serving natural, organic, and sports nutrition brands.
Ceapro Inc.
Ceapro is a Canadian bioprocessing company focused on high-value oat-derived actives, including Beta Glucan for cosmetics and healthcare.
Ohly GmbH
Ohly offers yeast-based taste and functional ingredients, including Beta Glucan for immune-support in savory and plant-based products.
Angel Yeast Co., Ltd.
Angel Yeast is a major yeast producer supplying cost-competitive Beta Glucan for human, animal, and pet nutrition, especially in Asia.
SWOT Leaders
Kerry Group plc (Wellmune & Beta Glucan Portfolio)
SWOT Snapshot
Global commercial reach, clinically proven Wellmune brand, strong relationships with top CPGs and supplement companies.
Premium pricing relative to regional competitors, portfolio concentration in immune-health positioning.
Mainstream adoption of immune fortification in beverages and snacks, expansion in emerging markets and direct-to-consumer channels.
Commoditization of generic yeast Beta Glucan, tightening health-claim regulations, and potential ingredient substitution by novel actives.
Cargill Incorporated
SWOT Snapshot
Integrated oat and barley supply chains, multi-region plants, strong R&D application capabilities for large food brands.
Less focus on high-purity nutraceutical segments, brand visibility lower at consumer level.
Rising demand for heart-health and cholesterol-lowering claims in mass-market foods across North America and Europe.
Weather and crop volatility affecting cereal sourcing, competition from specialized fiber players, evolving labeling rules on fiber claims.
DSM-Firmenich AG
SWOT Snapshot
Science-driven business model, strong clinical data, pharma-compliant manufacturing, integrated premix and personalization capabilities.
Higher cost base, complex organization, and longer development timelines for new Beta Glucan offerings.
Growth in medical nutrition, immune-support therapies, and personalized supplementation requiring clinically validated Beta Glucan.
Pricing pressure from generic suppliers, regulatory scrutiny on immune claims, macroeconomic headwinds affecting premium supplements demand.
Beta Glucan Market Regional Competitive Landscape
North America remains one of the largest and most sophisticated markets, driven by strong supplement consumption, functional foods penetration, and advanced healthcare spending. Kerry, Cargill, DSM-Firmenich, and Biothera anchor the competitive field, while regional Beta Glucan market companies leverage sports nutrition, lifestyle immunity products, and e-commerce channels for rapid share gains.
In Europe, consumer familiarity with oat fibers, EFSA-approved heart-health claims, and robust bakery and cereal industries support Beta Glucan uptake. Cargill, Tate & Lyle, Ohly, and Lesaffre play prominent roles. European Beta Glucan market companies emphasize clean-label sourcing, organic certifications, and sustainability, with strong interest in cholesterol and glycemic control applications.
Asia Pacific is the fastest-growing region, supported by rising middle-class incomes, proactive immunity positioning post-pandemic, and urbanization. Angel Yeast, Kerry, and regional manufacturers compete aggressively on price and localized formulations. Many Beta Glucan market companies focus on convenient beverage formats, fortified instant foods, and rapidly scaling pet nutrition categories.
Latin America shows emerging but accelerating demand, tied to expansion of modern retail, growth of fortified dairy, and evolving regulatory acceptance of functional claims. Lesaffre and Cargill, alongside local Beta Glucan market companies, deploy cost-effective fortification strategies targeting bakery, beverages, and affordable supplements positioned around immunity and metabolic health.
In the Middle East and Africa, the market is nascent but shaped by rising lifestyle disease incidence, growing interest in fortified staples, and expanding modern pharmacy chains. Global Beta Glucan market companies mainly operate through distributors, focusing on imported supplements and fortified dairy powders, while local players experiment cautiously with bakery and beverage applications.
Beta Glucan Market Emerging Challengers & Disruptive Start-Ups
Emerging Challengers & Disruptive Start-Ups
Develops precision-engineered Beta Glucan nanoparticles designed to enhance bioavailability and targeted immune modulation for sports, oncology, and respiratory health formulations.
Utilizes low-carbon, regenerative oat farming and enzyme-assisted extraction to deliver ultra-pure, traceable Beta Glucan for premium functional beverages and cereals.
Focuses on mushroom-derived Beta Glucan complexes, combining multiple polysaccharides to create differentiated immune formulas for nutraceutical and medical nutrition brands.
Operates a fermentation-based platform producing customizable yeast Beta Glucan tailored to regional taste profiles and functional needs of Asian food and beverage brands.
Integrates local cereal crops and sustainable processing to offer cost-competitive Beta Glucan ingredients targeting Latin American bakeries and fortified staple foods.
Beta Glucan Market Future Outlook & Key Success Factors (2026-2032)
From 2025 to 2031, cumulative investments in metro expansions and station safety upgrades are projected to surpass significant amounts. The total market will scale from US$ 2.27 Billionin 2025 to US$ 3.38 Billion by 2031, reflecting a 6.90% CAGR. Winning Beta Glucan market companies will share several attributes. First, they will embed native IoT sensors, enabling predictive maintenance contracts that can double recurring revenue within five years. Second, modular design philosophies—interchangeable panels, plug-and-play controllers—will shorten installation windows and appeal to cost-sensitive public operators.
Localization strategies will also define competitive edges. Suppliers that establish regional assembly plants to meet content rules in India, Brazil, or the U.S. are likely to capture bonus points in tenders. Finally, sustainability credentials will move from optional to mandatory. Recyclable composite panels, energy-efficient brushless motors, and life-cycle carbon disclosures will become bid differentiators. In short, the coming decade rewards Beta Glucanmarket companies that marry digital intelligence with manufacturing agility and regulatory foresight.
Frequently Asked Questions
Find answers to common questions about this company report.